(Q34874414)

5 August 2017

1 reference

title

Interactions between recreational drugs and antiretroviral agents (English)

1 reference

5 August 2017

main subject

anti-retroviral agent

0 references

author name string

Tony Antoniou

series ordinal

1 reference

5 August 2017

Alice Lin-In Tseng

series ordinal

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Annals of Pharmacotherapy

5 August 2017

published in

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

1598-1613

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

5 August 2017

cites work

1 reference

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

21 January 2018

1 reference

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

HIV-1 protease inhibitors. A review for clinicians

21 January 2018

1 reference

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

21 January 2018

1 reference

Drug interactions in patients infected with human immunodeficiency virus

21 January 2018

1 reference

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

21 January 2018

1 reference

Fatal interaction between ritonavir and MDMA

21 January 2018

1 reference

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 January 2018

1 reference

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

21 January 2018

1 reference

Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department

21 January 2018

1 reference

Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate

21 January 2018

1 reference

The influence of anesthetic agents on rat hepatic cytochromes P450 in vivo

21 January 2018

1 reference

Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo

21 January 2018

1 reference

Effects of inducers and/or inhibitors on metabolism of lysergic acid diethylamide in rat liver microsomes

21 January 2018

1 reference

Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4

21 January 2018

1 reference

The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz

21 January 2018

1 reference

Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone

21 January 2018

1 reference

Decreased methadone effect after ritonavir initiation

21 January 2018

1 reference

Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users

21 January 2018

1 reference

Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir

21 January 2018

1 reference

A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio

21 January 2018

1 reference

Interaction of methadone with substrates of human hepatic cytochrome P450 3A4.

21 January 2018

1 reference

Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone

21 January 2018

1 reference

Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities

21 January 2018

1 reference

Clinical pharmacokinetics of pethidine: 1982.

21 January 2018

1 reference

The effect of ritonavir on the pharmacokinetics of meperidine and normeperidine

21 January 2018

1 reference

In vitro forecasting of drugs that may interfere with codeine bioactivation

21 January 2018

1 reference

Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone

21 January 2018

1 reference

Loss of analgesic effect of morphine due to coadministration of rifampin

21 January 2018

1 reference

Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team

21 January 2018

1 reference

Metabolism of cocaine in man

21 January 2018

1 reference

Cocaine metabolism and urinary excretion after different routes of administration

21 January 2018

1 reference

Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterases

21 January 2018

1 reference

Norcocaine and N-hydroxynorcocaine formation in human liver microsomes: role of cytochrome P-450 3A4.

21 January 2018

1 reference

Cocaine metabolism in human fetal and adult liver microsomes is related to cytochrome P450 3A expression

21 January 2018

1 reference

Association between life-threatening cocaine toxicity and plasma cholinesterase activity

21 January 2018

1 reference

The pharmacokinetics of heroin in patients with chronic pain

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of smoked heroin.

21 January 2018

1 reference

Alprazolam is another substrate for human cytochrome P450-3A isoforms.

21 January 2018

1 reference

Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam

21 January 2018

1 reference

Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction

21 January 2018

1 reference

Identification of the human and animal hepatic cytochromes P450 involved in clonazepam metabolism

21 January 2018

1 reference

Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes

21 January 2018

1 reference

The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir

21 January 2018

1 reference

Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults

21 January 2018

1 reference

Cytochrome P450 2D6 Genotype and Methadone Steady-State Concentrations

21 January 2018

1 reference

Efavirenz decreases methadone blood concentrations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A447

1 reference

5 August 2017

1 reference